**Core Concept**
The treatment duration for multibacillary leprosy is based on the **World Health Organization (WHO)** guidelines, which recommend a specific regimen and duration to ensure cure and prevent resistance. Multibacillary leprosy is characterized by a higher bacterial load, requiring a longer treatment duration. The standard treatment regimen includes a combination of **rifampicin**, **clofazimine**, and **dapsone**.

**Why the Correct Answer is Right**
The correct answer is based on the WHO-recommended treatment duration for multibacillary leprosy, which is **12 months**. This duration is necessary to ensure that the bacteria are fully eradicated, reducing the risk of relapse and resistance. The treatment regimen includes **rifampicin**, a potent bactericidal agent, **clofazimine**, which has antimicrobial and anti-inflammatory properties, and **dapsone**, a bacteriostatic agent.

**Why Each Wrong Option is Incorrect**
**Option A:** Is incorrect because it is too short, and **Option B:** and **Option D:** are incorrect because they are not the recommended duration.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that multibacillary leprosy requires a longer treatment duration than paucibacillary leprosy, and adherence to the full treatment regimen is crucial to prevent relapse and resistance. The WHO-recommended treatment duration for multibacillary leprosy is **12 months**.

**Correct Answer:** D. 12 months.